Allosteric Neutralization by Human H7N9 Antibodies

The avian influenza A virus H7N9 causes severe human infections with more than 30% fatality despite the use of neuraminidase inhibitors. Currently there is no H7N9-specific prevention or treatment for humans. From a 2013 H7N9 convalescent case occurred in Hong Kong, we isolated four H7 hemagglutinin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Manxue, Zhao, Hanjun, Morano, Nicholas C., Lu, Hong, Lui, Yin-Ming, Du, Haijuan, Becker, Jordan E., Yuen, Kwok-Yung, Ho, David D., Kwong, Peter D., Shapiro, Lawrence, To, Kelvin Kai-Wang, Wu, Xueling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659534/
https://www.ncbi.nlm.nih.gov/pubmed/37986867
http://dx.doi.org/10.21203/rs.3.rs-3429355/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659534/
https://www.ncbi.nlm.nih.gov/pubmed/37986867
http://dx.doi.org/10.21203/rs.3.rs-3429355/v1

Ejemplares similares